People · Operator
Named in public records as an officer, director or promoter · active 2017–2020 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LumiraDx Ltd | — | Other Health Care | Series D+ | $779.1M | $3.5B | 2017 |
| Stealth BioTherapeutics Corp | — | Biotechnology | Series B | $35.0M | $793.8M | 2019 |
Lu Huang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lu Huang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gerald Chan | 2 | 13 |
| David Scott | 1 | 12 |
| RON ZWANZIGER | 1 | 6 |
| David Walton | 1 | 3 |
| George Neble | 1 | 3 |
| Donald Berwick | 1 | 3 |
| Francis Chen | 1 | 3 |
| Jerry McAleer | 1 | 2 |
| Peter Scheu | 1 | 2 |
| Lurene Joseph | 1 | 1 |
| Troyen Brennan | 1 | 1 |
| Amit Thakker | 1 | 1 |
| Dorian LeBlanc | 1 | 1 |
| Nigel Lindner | 1 | 1 |
| Veronique Ameye | 1 | 1 |
| Tom Quinlan | 1 | 1 |
| Irene McCarthy | 1 | 1 |
| Peter Welch | 1 | 1 |
| Suresh Vazirani | 1 | 1 |
| Sumit Nagpal | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.